Elutia Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women’s Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Others were interested in
See all stocksFrequently asked questions
To buy Elutia Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Elutia Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Elutia Inc. is ELUT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Elutia Inc. has its primary listing on NASDAQ. You can trade Elutia Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Elutia Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Elutia Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Elutia Inc..